Overview
Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women
Status:
Unknown status
Unknown status
Trial end date:
2016-12-01
2016-12-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
This study is for compare the efficacy of two different regimens(vaginal vs intramuscular) of progesterone therapy in prevention of preterm birth in high risk pregnant women.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Ewha Womans University Mokdong HospitalCollaborators:
Han Wha Pharma Co., Ltd.
Ministry of Health & Welfare, Korea
Samsung Medical CenterTreatments:
Progesterone
Criteria
Inclusion Criteria:- With a history of prior spontaneous preterm birth or short cervix length
- Spontaneous preterm birth: preterm birth <37 weeks of gestation due to spontaneous
preterm labor or preterm premature rupture of membranes (PPROM)
- Short Cervix length : cervix length <25 mm as measured by transvaginal ultrasound at
16-24 weeks of gestation
Exclusion Criteria:
- Multiple gestations
- Major congenital anomalies
- Elective prophylactic cervical cerclage <16 weeks of gestation during current
pregnancy
- Previous intentional preterm birth due to maternal or fetal indications, such as
preeclampsia and fetal growth restriction
- Diabetes, hypertension, other severe medical diseases